Vol. 42 No. Suppl. 1 (2014)

Original

• Expert Recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)

  José A. Alda, César Soutullo, Josep A. Ramos-Quiroga, Javier Quintero, Amaia Hervás, Isabel Hernández-Otero, Anna Sans-Fitó, Esther Cardo-Jalón, Alberto Fernández-Jaén, Maximino Fernández-Pérez, Mª Inés Hidalgo-Vicario, Lefa S. Eddy-Ives, Javier Sánchez

  1-16

  • PDF
  • PDF (Español (España))